Arsenic Plasma Concentrations and Methylation Efficiency as Key Factors of Arsenic Trioxide-Related Cardiac Toxicity in Acute Promyelocytic Leukemia
Cardiovascular Toxicology · 2026-07 · 26 (7)
DOI: 10.1007/s12012-026-10141-8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cardiovascular Toxicology, online erschienen am 08.07.2026. Verfasst von Meihua Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Arsenic Trioxide, Leukemia, Promyelocytic, Acute. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, Scientific Research Project of Wu Jieping Medical Foundation, fundamental research funds for China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Arsenic trioxide (ATO) is highly effective for acute promyelocytic leukemia (APL), but ATO-induced cardiac adverse events (CAEs) frequently cause treatment interruption or fatal outcomes, and real-world evidence linking arsenic species levels, methylation capacity, and CAE risk remains limited. In this study, we included 547 APL patients treated with ATO between 2014 and 2024 (4741 treatment cycles). Plasma concentrations of inorganic arsenic (iAs), monomethylated arsenic (MMA), and dimethylated arsenic (DMA) were measured in 374 patients using HPLC-HG-AFS. Primary (PMI = MMA/iAs) and secondary (SMI = DMA/MMA) methylation indices were calculated. Univariate and multivariate Cox regression identified independent CAE determinants, ROC analysis evaluated predictive values and cutoffs, and a risk nomogram was constructed. CAEs occurred in 297 patients (54.3%) and 554 treatment cycles (11.7%). Plasma arsenic distribution followed DMA, MMA > iAs, with PMI > SMI (all P < 0.05). Patients with CAEs had significantly higher DMA, iAs, total arsenic (tAs), and aberrant methylation profiles (all P < 0.05). Concomitant cardiotoxic drug use, DMA, tAs, SMI, DMA%, and MMA% were independent determinants. ROC analysis demonstrated good predictive performance for these markers (AUCs 0.708-0.869). The nomogram showed favorable discrimination (C-index = 0.823) and clinical net benefit. ECG abnormalities were the most common CAEs. ATO-induced cardiotoxicity is closely related to arsenic species concentration and methylation metabolism; importantly, impaired primary methylation (lower PMI, lower MMA%) appears to be the key bottleneck, with secondary methylation enhanced as a compensatory response (higher SMI, higher DMA%). Arsenic toxicokinetic and methylation markers effectively predict CAEs, supporting routine therapeutic drug monitoring in APL patients receiving ATO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Heilongjiang Province Key Laboratory of Precision Pharmaceutical Research, Harbin, China.
- School of Pharmacy, Qiqihar Medical University, Qiqihar, China.
- Department of Haematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
- Department of Pharmacy, The First Affiliated Hospital of Harbin Medical University, Harbin, China. haixin@hrbmu.edu.cn.
Förderung
- Natural Science Foundation of Heilongjiang Province
- Scientific Research Project of Wu Jieping Medical Foundation
- fundamental research funds for China Postdoctoral Science Foundation
- provincial universities in heilongjiang province
- National Natural Science Foundation of China
- Key Project of Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Guo, M., Yue, C., Liu, Y., Zhao, T., Ni, X., Guo, Z., Ren, S., Gao, Z., Zhang, W., Li, L., Husam, A. M., & Hai, X. (2026). Arsenic Plasma Concentrations and Methylation Efficiency as Key Factors of Arsenic Trioxide-Related Cardiac Toxicity in Acute Promyelocytic Leukemia. Cardiovascular Toxicology, 26(7). https://doi.org/10.1007/s12012-026-10141-8
Vancouver
Guo M, Yue C, Liu Y, Zhao T, Ni X, Guo Z, et al. Arsenic Plasma Concentrations and Methylation Efficiency as Key Factors of Arsenic Trioxide-Related Cardiac Toxicity in Acute Promyelocytic Leukemia. Cardiovascular Toxicology. 2026;26(7). doi:10.1007/s12012-026-10141-8
BibTeX
@article{Guo2026,
author = {Guo, Meihua and Yue, Chenli and Liu, Yutong and Zhao, Tianyu and Ni, Xiaoting and Guo, Zhibo and Ren, Shi'ao and Gao, Zengliang and Zhang, Wenlei and Li, Longyu and Husam, Al-Mhmody and Hai, Xin},
title = {Arsenic Plasma Concentrations and Methylation Efficiency as Key Factors of Arsenic Trioxide-Related Cardiac Toxicity in Acute Promyelocytic Leukemia},
journal = {Cardiovascular Toxicology},
year = {2026},
volume = {26},
number = {7},
doi = {10.1007/s12012-026-10141-8}
}
EUVIMED